Valeo Pharma (CSE: VPH – OTCQB: VPHIF) CEO Steve Saviuk joined Steve Darling from Proactive to share news the company has started the commercialization of their asthma products Enerzair Breezhaler and Atectura Breezhaler .
Saviuk telling Proactive, shipments have started across Canada have started and the initial deployment of its national respiratory sales force has begun.